Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Eurofins Ntd Llc |
RCV000176894 | SCV000228657 | uncertain significance | not provided | 2015-05-13 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000534726 | SCV000643280 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-02-08 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV002336432 | SCV002639293 | uncertain significance | Cardiovascular phenotype | 2019-02-28 | criteria provided, single submitter | clinical testing | The p.I1615V variant (also known as c.4843A>G), located in coding exon 26 of the TTN gene, results from an A to G substitution at nucleotide position 4843. The isoleucine at codon 1615 is replaced by valine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
| Revvity Omics, |
RCV000176894 | SCV003827352 | uncertain significance | not provided | 2023-11-17 | criteria provided, single submitter | clinical testing | |
| Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV005404332 | SCV006067879 | likely benign | not specified | 2025-04-09 | criteria provided, single submitter | clinical testing |